NewsBenzingaAmylyxファーマ、ObesityWeek 2026年年次会議でアベキシタイドの有効性と安全性を示す第3相トップラインデータを発表へ Amylyxファーマ、ObesityWeek 2026年年次会議でアベキシタイドの有効性と安全性を示す第3相トップラインデータを発表へ Benzinga 2026.10.06 12:07 (GMT+0) Open on Benzinga Other news TD Cowen Maintains Buy on Capital One Financial, Lowers Price Target to $242 Lamb Weston Beats Q1 Expectations, Raises 2027 Outlook As Cost-Saving Efforts Gain Traction Raymond James Downgrades Wesbanco to Market Perform TD Cowen Maintains Hold on Credit Acceptance, Lowers Price Target to $590 TD Cowen Maintains Hold on Bread Financial Holdings, Lowers Price Target to $111 Raymond James Downgrades Hilltop Hldgs to Underperform
